About
Drugs to treat diseases associated with excess body fat
Areas of Focus
Categories
San Diego & Southern California
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
2,992
By Phase
PHASE3: 2
By Status
COMPLETED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT07131371Collaborator
Stratification, Management, and Guidance of Hypertrophic Cardiomyopathy Patients Using Hybrid Digital Twin Solutions
N/AActive, not recruiting
2,500 participants
Started: Jan 15, 2024 · Completed: Dec 31, 2028
NCT05033145Lead Sponsor
Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)
PHASE3Completed
312 participants
Started: Jan 15, 2022 · Completed: Jul 27, 2022
NCT04668235Lead Sponsor
Study on Safety and Clinical Efficacy of AZVUDINE in COVID-19 Patients (SARS-CoV-2 Infected)
PHASE3Completed
180 participants
Started: Apr 23, 2021 · Completed: Aug 10, 2022
Funding History (1)
D
Nov 21, 2019
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...